Morison commences local production of three high-in-demand medicines | Daily News

Morison commences local production of three high-in-demand medicines

Morison Ltd., a pioneer in pharmaceutical manufacturing in Sri Lanka (formerly known as J.L. Morison’s Son and Jones (Ceylon) PLC), Morison commences local production of three high-in-demand medicines

Morison commenced operations of their latest state-of-the-art manufacturing and research facility in Homagama in May this year, which is the largest investment to date in the pharmaceutical manufacturing industry in Sri Lanka. This will be a great boost for the pharmaceutical supply of the country during this crucial hour.

Dinesh Athapaththu, Managing Director of Morison Limited, said, “This indeed is a key milestone for Morison as well as the pharmaceutical manufacturing industry in the country.”

“Our new branded pharmaceutical range as such offers six Unique Value Propositions (UVPs) which are precisely being Truly Sri Lankan, offering Global Quality, at a Local Price, introducing Novel therapies, through a purely Ethical framework whilst being a credible pharmaceutical brand that our people can rely on.”

Morison commenced manufacturing of Bisoprolol tablets B.P. 5mg 250s, Ros-10 (Rosuvastatin tablets I.P. 10mg 30s blister), and ChlorMor (Chlorphenamine tablets B.P. 4mg 100s blister) recently. This marks a milestone in the local pharmaceutical industry, as these high-in-demand medicines are now more affordable and accessible to our people, the supply of which does not have to depend on imports.

For the first time in Sri Lanka, Bisoprolol 5 mg tablets are now being manufactured locally by Morison and supplied to the Medical Supplies Division for the use in government hospitals.


Add new comment